Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery Journal Article


Authors: Cox, B. W.; Jackson, A.; Hunt, M.; Bilsky, M.; Yamada, Y.
Article Title: Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery
Abstract: Purpose: To report the esophageal toxicity from single-fraction paraspinal stereotactic radiosurgery (SRS) and identify dosimetric and clinical risk factors for toxicity. Methods and Materials: A total of 204 spinal metastases abutting the esophagus (182 patients) were treated with high-dose single-fraction SRS during 2003-2010. Toxicity was scored using the National Cancer Institute Common Toxicity Criteria for Adverse Events, version 4.0. Dose-volume histograms were combined to generate a comprehensive atlas of complication incidence that identifies risk factors for toxicity. Correlation of dose-volume factors with esophageal toxicity was assessed using Fisher's exact test and logistic regression. Clinical factors were correlated with toxicity. Results: The median dose to the planning treatment volume was 24 Gy. Median follow-up was 12 months (range, 3-81). There were 31 (15%) acute and 24 (12%) late esophageal toxicities. The rate of grade ≥3 acute or late toxicity was 6.8% (14 patients). Fisher's exact test resulted in significant median splits for grade ≥3 toxicity at V12 = 3.78 cm 3 (relative risk [RR] 3.7, P=.05), V15 = 1.87 cm 3 (RR 13, P=.0013), V20 = 0.11 cm 3 (RR 6, P=0.01), and V22 = 0.0 cm 3 (RR 13, P=.0013). The median split for D2.5 cm 3 (14.02 Gy) was also a significant predictor of toxicity (RR 6; P=.01). A highly significant logistic regression model was generated on the basis of D2.5 cm 3. One hundred percent (n = 7) of grade ≥4 toxicities were associated with radiation recall reactions after doxorubicin or gemcitabine chemotherapy or iatrogenic manipulation of the irradiated esophagus. Conclusions: High-dose, single-fraction paraspinal SRS has a low rate of grade ≥3 esophageal toxicity. Severe esophageal toxicity is minimized with careful attention to esophageal doses during treatment planning. Iatrogenic manipulation of the irradiated esophagus and systemic agents classically associated with radiation recall reactions are associated with development of grade ≥4 toxicity. © 2012 Elsevier Inc. All rights reserved.
Keywords: adult; aged; middle aged; young adult; major clinical study; doxorubicin; treatment planning; gemcitabine; chemotherapy; follow up; follow-up studies; edema; esophagitis; logistic models; radiotherapy; risk factors; radiation injury; risk factor; dose-response relationship, radiation; tumor burden; dosimetry; radiosurgery; spinal neoplasms; radiation injuries; stereotactic radiosurgery; toxicity; regression analysis; igrt; statistics, nonparametric; esophagus; radiation sickness; spinal cord metastasis; histogram; spine radiosurgery; high dose; dose-volume; adverse events; paraspinal; esophagus ulcer; drug products; national cancer institute; esophagus injury; low rates; relative risks; logistics; logistic regression models; treatment volumes; medical illustration; esophageal toxicity; paraspinal sbrt; spine tumors; dose-volume histograms; clinical risks; exact tests; logistic regressions; esophagus fistula
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 83
Issue: 5
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2012-08-01
Start Page: e661
End Page: e667
Language: English
DOI: 10.1016/j.ijrobp.2012.01.080
PROVIDER: scopus
PMCID: PMC3392527
PUBMED: 22572079
DOI/URL:
Notes: --- - "Export Date: 1 August 2012" - "CODEN: IOBPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brett Wayne Cox
    63 Cox
  2. Yoshiya Yamada
    479 Yamada
  3. Mark H Bilsky
    319 Bilsky
  4. Andrew Jackson
    253 Jackson
  5. Margie A Hunt
    287 Hunt